Dentalcare logo

Epinephrine: Friend or Foe?

COURSE NUMBER: 547

Credit Hours:

3 Hour(s)

This course will provide evidence-based information essential for determining the therapeutic dose of epinephrine to minimize toxicity when treating anaphylaxis or when epinephrine is used as a vasoconstrictor in conjunction with local anes...

View More

(Use this feature to create assignments for your students and staff.)

Overview

This course will provide evidence-based information essential for determining the therapeutic dose of epinephrine to minimize toxicity when treating anaphylaxis or when epinephrine is used as a vasoconstrictor in conjunction with local anesthesia.


This continuing dental education course presents the physiological basis of adrenergic pharmacology. It discusses the safe and effective use of epinephrine in the treatment of anaphylaxis and as a vasoconstrictor administered in conjunction with local anesthetic agents. The objective of this course is to provide evidence-based information essential for determining the therapeutic dose of epinephrine to minimize toxicity when treating anaphylaxis or when epinephrine is used as a vasoconstrictor in conjunction with local anesthesia.

  • Intended Audience:

    Dental Assistants, Dental Hygiene Students, Dental Hygienists, Dental Students, Dentists, Dental Assistant Students

  • Date Course Online:

    Feb 28, 2018

  • Last Revision Date:

    Dec 31, 2000

  • Course Expiration Date:

    Feb 27, 2021

  • Cost:

    Free

  • Method:

    Self-instructional

  • AGD Subject Code(s):

Learning Objectives

Upon completion of this course, the dental professional should be able to:


  • Discuss the relevance of the top 300 drugs dispensed by U.S. community pharmacies.
  • Describe and discuss the relevance of epinephrine formulations in the Top 300 Drugs.
  • Describe the mechanism of action and pharmacokinetics of epinephrine.
  • Explain the treatment of anaphylaxis in oral healthcare settings.
  • Explain the use of epinephrine as adjuvant in local anesthetic formulations.

Disclaimers

Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy. Note:  Registration is required to take test.

Author(s)

Conflict of Interest Disclosure Statement

  • Dr. Taifour reports no conflicts of interest associated with this course.
  • Dr. Terézhalmy has done consulting work for Procter & Gamble and has served on the dentalcare.com Advisory Board.

Submission Information

Recognition

AGD Pace Logo

Approved PACE Program Provider

THE PROCTER & GAMBLE COMPANY


Nationally Approved PACE Program Provider for FAGD/MAGD credit.

Approval does not imply acceptance by any regulatory authority or AGD endorsement.


8/1/2021 to 7/31/2027

Provider ID# 211886